Acerus Pharmaceuticals Probability of Future OTC Stock Price Finishing Over 0.2178
| ASPCFDelisted Stock | USD 0.22 0.00 0.00% |
Acerus |
Acerus Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acerus Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acerus Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Acerus Pharmaceuticals is not yet fully synchronised with the market data | |
| Acerus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Acerus Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Acerus Pharmaceuticals has accumulated 21.14 M in total debt with debt to equity ratio (D/E) of 2.61, implying the company greatly relies on financing operations through barrowing. Acerus Pharmaceuticals has a current ratio of 0.36, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Acerus Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Acerus Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acerus Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acerus to invest in growth at high rates of return. When we think about Acerus Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (33.82 M) with profit before overhead, payroll, taxes, and interest of 1 M. | |
| Acerus Pharmaceuticals has accumulated about 1.29 M in cash with (23.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17. | |
| Roughly 91.0% of Acerus Pharmaceuticals shares are held by company insiders |
Acerus Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acerus OTC Stock often depends not only on the future outlook of the current and potential Acerus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acerus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 B |
Acerus Pharmaceuticals Technical Analysis
Acerus Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Acerus OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Acerus Pharmaceuticals. In general, you should focus on analyzing Acerus OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Acerus Pharmaceuticals Predictive Forecast Models
Acerus Pharmaceuticals' time-series forecasting models is one of many Acerus Pharmaceuticals' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Acerus Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Acerus Pharmaceuticals
Checking the ongoing alerts about Acerus Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Acerus Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Acerus Pharmaceuticals is not yet fully synchronised with the market data | |
| Acerus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Acerus Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Acerus Pharmaceuticals has accumulated 21.14 M in total debt with debt to equity ratio (D/E) of 2.61, implying the company greatly relies on financing operations through barrowing. Acerus Pharmaceuticals has a current ratio of 0.36, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Acerus Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Acerus Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acerus Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acerus to invest in growth at high rates of return. When we think about Acerus Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (33.82 M) with profit before overhead, payroll, taxes, and interest of 1 M. | |
| Acerus Pharmaceuticals has accumulated about 1.29 M in cash with (23.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17. | |
| Roughly 91.0% of Acerus Pharmaceuticals shares are held by company insiders |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Acerus Pharmaceuticals information on this page should be used as a complementary analysis to other Acerus Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Acerus OTC Stock
If you are still planning to invest in Acerus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acerus Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |